PDCI Market Access conducts research and analysis on behalf of industry and government clients. These studies examine the economic, political, intellectual property and healthcare policy factors that affect the pharmaceutical industry in Canada and internationally. Our industry clients include major pharmaceutical manufacturers and industry associations who rely on our expertise, experience and analysis in support of their strategic planning and government relations activities.

Parallel (Cross-Border) Trade

• PDCI Market Access conducts evaluations of the risk of parallel trade.

International Price Comparisons

• Economic research & analysis – trends and analysis of economic data and indicators pertaining to the pharmaceutical industry in Canada and internationally. PDCI Market Access conducts ongoing analysis of key economic indicators for the pharmaceutical sector and has completed several major economic studies:

  • Canada's Balance of Trade in Pharmaceuticals

  • Parliamentary Review of Bill C-91: Background Study on Costs & Benefits

  • Cost Impact of a National Pharmacare Program

Pricing Trends & Outlook

• Market research – market analysis to assist clients evaluate the market potential for new molecules, forecasting product life cycles and estimating the impact of brand and generic competitors

Comparative Analyses of Pricing & Reimbursement Policies

• Policy research - policy research to assist industry clients understand the issues and underlying factors affecting some of the key policy issues affecting the pharmaceutical industry including:

  • Price regulation, Patented Medicine Prices Review Board (PMPRB)

  • Reimbursement policies: provincial, federal, private, "National Pharmacare"

  • Intellectual property issues: patent term extension/restoration, linkage regulations, data protection, stockpiling/early working, orphan drugs

  • International Price Comparisons, rationale and implications

  • Parallel trade, impact of international price differentials, US drug reimportation polices

  • Direct to Consumer (DTC) Advertising

• Health/pharmacoeconomics - PDCI Market Access prepares pharmacoeconomic analysis in support of reimbursement submissions to provincial drug plans and to justify prices to the Patented Medicine Prices Review Board (PMPRB). All pharmacoeconomic analyses are conducted in accordance with established guidelines (Ontario, CCOHTA).